FDA Clears Rapid, Point-of-Care Test to Detect Chlamydia, Gonorrhea
The FDA has granted 510(k) clearance to binx io (binx health) for women’s health, a molecular point-of-care diagnostic testing platform for detecting chlamydia and gonorrhea in approximately 30 minutes.